CCKAR
Basic information
Region (hg38): 4:26481396-26490484
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCKAR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 26 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 1 | 0 |
Variants in CCKAR
This is a list of pathogenic ClinVar variants found in the CCKAR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-26481663-A-T | not specified | Uncertain significance (Nov 20, 2023) | ||
4-26481723-C-T | not specified | Uncertain significance (Jun 05, 2023) | ||
4-26481826-G-T | not specified | Uncertain significance (Jan 04, 2022) | ||
4-26481832-C-T | CHOLECYSTOKININ A RECEPTOR POLYMORPHISM | Benign (-) | ||
4-26481840-G-T | not specified | Uncertain significance (Feb 15, 2023) | ||
4-26481891-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
4-26481904-C-T | not specified | Uncertain significance (Dec 02, 2022) | ||
4-26481926-G-T | not specified | Uncertain significance (Jun 22, 2021) | ||
4-26481931-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
4-26481946-T-C | not specified | Uncertain significance (Jun 16, 2023) | ||
4-26481975-A-G | not specified | Uncertain significance (May 24, 2024) | ||
4-26482032-C-A | not specified | Uncertain significance (Jun 23, 2021) | ||
4-26482126-C-T | not specified | Uncertain significance (Apr 27, 2022) | ||
4-26482129-T-A | not specified | Uncertain significance (Jan 31, 2024) | ||
4-26482129-T-C | not specified | Uncertain significance (Feb 23, 2023) | ||
4-26483216-T-C | not specified | Uncertain significance (Oct 26, 2022) | ||
4-26483259-G-A | Likely benign (Jul 20, 2018) | |||
4-26483278-G-C | not specified | Uncertain significance (Nov 12, 2021) | ||
4-26485688-G-A | not specified | Uncertain significance (Aug 01, 2022) | ||
4-26485693-G-T | not specified | Uncertain significance (May 27, 2022) | ||
4-26485739-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
4-26485814-C-G | not specified | Uncertain significance (Jan 16, 2024) | ||
4-26485838-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
4-26485884-C-T | not specified | Uncertain significance (Aug 08, 2023) | ||
4-26489244-G-A | not specified | Uncertain significance (Nov 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCKAR | protein_coding | protein_coding | ENST00000295589 | 5 | 9063 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00403 | 0.963 | 125654 | 0 | 94 | 125748 | 0.000374 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.309 | 255 | 269 | 0.947 | 0.0000170 | 2805 |
Missense in Polyphen | 107 | 113.55 | 0.94234 | 1191 | ||
Synonymous | -0.458 | 119 | 113 | 1.05 | 0.00000773 | 877 |
Loss of Function | 1.87 | 6 | 13.4 | 0.449 | 5.65e-7 | 163 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.000899 | 0.000893 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00209 | 0.00209 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for cholecystokinin. Mediates pancreatic growth and enzyme secretion, smooth muscle contraction of the gall bladder and stomach. Has a 1000-fold higher affinity for CCK rather than for gastrin. It modulates feeding and dopamine-induced behavior in the central and peripheral nervous system. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system.;
- Pathway
- Calcium signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Insulin secretion - Homo sapiens (human);Peptide GPCRs;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- loftool
- 0.647
- rvis_EVS
- -0.13
- rvis_percentile_EVS
- 43.91
Haploinsufficiency Scores
- pHI
- 0.401
- hipred
- Y
- hipred_score
- 0.506
- ghis
- 0.444
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.613
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cckar
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; respiratory system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; renal/urinary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; taste/olfaction phenotype; growth/size/body region phenotype; craniofacial phenotype;
Gene ontology
- Biological process
- neuron migration;G protein-coupled receptor signaling pathway;phospholipase C-activating G protein-coupled receptor signaling pathway;axonogenesis;feeding behavior;forebrain development;cellular response to hormone stimulus;cholecystokinin signaling pathway;regulation of hormone secretion
- Cellular component
- plasma membrane;integral component of plasma membrane;membrane
- Molecular function
- cholecystokinin receptor activity;peptide hormone binding